<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T19:13:13Z</responseDate>
  <request identifier="oai:figshare.com:article/33974674" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33974674</identifier>
        <datestamp>2026-09-23T17:21:38Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Preprocessing script.&lt;/p&gt;</dc:title>
          <dc:creator>Jan-Ole Hesselberg (21453807)</dc:creator>
          <dc:creator>Pål Ulleberg (522303)</dc:creator>
          <dc:creator>Øystein Sørensen (4767861)</dc:creator>
          <dc:creator>Knut Inge Fostervold (11509353)</dc:creator>
          <dc:creator>Sigrid Hegna Ingvaldsen (15359171)</dc:creator>
          <dc:creator>Ida Svege (11509356)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>general panel membership</dc:subject>
          <dc:subject>average iccs ranged</dc:subject>
          <dc:subject>human judgment rather</dc:subject>
          <dc:subject>structured review formats</dc:subject>
          <dc:subject>stable reviewer tendencies</dc:subject>
          <dc:subject>reviewer age composition</dc:subject>
          <dc:subject>moderate across funders</dc:subject>
          <dc:subject>substantially improve reliability</dc:subject>
          <dc:subject>systematic reviewer characteristics</dc:subject>
          <dc:subject>including reviewer similarity</dc:subject>
          <dc:subject>depth review procedures</dc:subject>
          <dc:subject>matter expertise rather</dc:subject>
          <dc:subject>examines factors associated</dc:subject>
          <dc:subject>slightly lower disagreement</dc:subject>
          <dc:subject>reviewer similarity</dc:subject>
          <dc:subject>review depth</dc:subject>
          <dc:subject>specific rather</dc:subject>
          <dc:subject>review roles</dc:subject>
          <dc:subject>multiple factors</dc:subject>
          <dc:subject>four funders</dc:subject>
          <dc:subject>reliability persist</dc:subject>
          <dc:subject>rater reliability</dc:subject>
          <dc:subject>lower disagreement</dc:subject>
          <dc:subject>application characteristics</dc:subject>
          <dc:subject>yet concerns</dc:subject>
          <dc:subject>variability arose</dc:subject>
          <dc:subject>temporal trends</dc:subject>
          <dc:subject>specific ambiguity</dc:subject>
          <dc:subject>reviewers selected</dc:subject>
          <dc:subject>reviewers disagree</dc:subject>
          <dc:subject>residual level</dc:subject>
          <dc:subject>research area</dc:subject>
          <dc:subject>registered report</dc:subject>
          <dc:subject>rater agreement</dc:subject>
          <dc:subject>program features</dc:subject>
          <dc:subject>primarily due</dc:subject>
          <dc:subject>leveraging data</dc:subject>
          <dc:subject>level ambiguity</dc:subject>
          <dc:subject>inherent variability</dc:subject>
          <dc:subject>greater responsibility</dc:subject>
          <dc:subject>grant evaluations</dc:subject>
          <dc:subject>expert reviews</dc:subject>
          <dc:subject>clearer criteria</dc:subject>
          <dc:subject>assessments conducted</dc:subject>
          <dc:subject>also associated</dc:subject>
          <dc:subject>absolute magnitude</dc:subject>
          <dc:subject>1 percent</dc:subject>
          <dc:description>&lt;p&gt;This script has been used for producing the primary data set used as the basis for the analysis script (see &lt;a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0356108#pone.0356108.s005" target="_blank"&gt;S2 File&lt;/a&gt;). This includes merging the data sets from the four funders and producing the explanatory variables based on variables that could be used to identify reviewers or applications (gender and birth year). Additionally, all application IDs and reviewer IDs are switched with anonymized IDs.&lt;/p&gt; &lt;p&gt;(TXT)&lt;/p&gt;</dc:description>
          <dc:date>2026-09-23T17:21:34Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0356108.s004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Preprocessing_script_p_/33974674</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
